Table 2. Malondialdehyde, carbonyl, thiol group, tail length, FRAP, DPPH quenching, NOx, vitamin C, reduced glutathione, superoxide dismutase, catalase, glutathione reductase, glutathione S transferase in control and RA patients.

	Control (n = 53)	RA Patient (n = 120)
Sex (M/F)	17/36	37/83
MDA (nmol/ml)	1.23±0.24	1.86±0.41*
Carbonyl (nmoles/mg protein)	1.07±1.09	1.39±0.14*
T-SH (μM)	454.12±54.39	321.39±49.24*
Tail length (μm)	4.03±0.63	8.47±1.61*
FRAP (μM)	816.64±71.56	619.37±70.12*
% quenching of DPPH	57.92±2.25	51.05±3.17*
NOx (μM)	8.34±1.68	14.21±0.87*
Vit C (mg/dl)	0.99±0.26	0.47±0.17*
GSH (nmoles/mg Hb)	5.49±1.23	3.84±1.06*
SOD (U/mg Hb)	1.48±0.18	1.05±0.27*
Catalase (U/mg Hb)	11.11±1.07	8.77±1.13*
GR (U/g Hb)	4.96±0.70	3.13±0.72*
GST (U/mg Hb)	0.64±0.69	0.73±0.12*

* p < 0.05